Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.
Recruiting
Observational Study
Breast Cancer
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- National Cancer Institute, Naples · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is multicentric, spontaneous, observational, retrospective and prospective study.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* TNBC breast cancer patients, before any drug treatment
* healthy women aged 25-60
Exclusion Criteria:
* donors suffering from diabetes, hypertension, active infectious states, HIV infection, Hepatitis B or C, chronic inflammatory diseases, current or previous neoplasms, hear…
Contacts